

Melatonin, also known as N-acetyl-5-methoxy tryptamine, is a hormone that is produced by the pineal gland in animals and regulates sleep and wakefulness. Melatonin is also produced in plants where it functions as a first line of defense against oxidative stress.
Highlights
The global Melatonin market was valued at US$ 1735.5 million in 2022 and is anticipated to reach US$ 4903.7 million by 2029, witnessing a CAGR of 18.9% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Neurim Pharma, Natrol, Pharmavite, Nature's Bounty and Jameison are the leaders of the Melatonin industry, which take about 30% market share. North America and Europe are the major region of the global market, which takes about 70% market share.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Melatonin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Melatonin.
The Melatonin market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Melatonin market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Melatonin companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Natrol
Pharmavite
Nature's Bounty
Jameison
Rexall Sundown
GNC
Xiu Zheng
Church & Dwight
By-Health
Pfizer
Solgar
Biotics Research
Now Food
Segment by Type
Pharmaceutical Grade Melatonin
Food Grade Melatonin
Segment by Application
Dietary Supplements
Medical
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Melatonin companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Âé¶¹Ô´´ Analysis by Type
1.2.1 Global Melatonin Âé¶¹Ô´´ Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Pharmaceutical Grade Melatonin
1.2.3 Food Grade Melatonin
1.3 Âé¶¹Ô´´ by Application
1.3.1 Global Melatonin Âé¶¹Ô´´ Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Dietary Supplements
1.3.3 Medical
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Melatonin Âé¶¹Ô´´ Perspective (2018-2029)
2.2 Melatonin Growth Trends by Region
2.2.1 Global Melatonin Âé¶¹Ô´´ Size by Region: 2018 VS 2022 VS 2029
2.2.2 Melatonin Historic Âé¶¹Ô´´ Size by Region (2018-2023)
2.2.3 Melatonin Forecasted Âé¶¹Ô´´ Size by Region (2024-2029)
2.3 Melatonin Âé¶¹Ô´´ Dynamics
2.3.1 Melatonin Industry Trends
2.3.2 Melatonin Âé¶¹Ô´´ Drivers
2.3.3 Melatonin Âé¶¹Ô´´ Challenges
2.3.4 Melatonin Âé¶¹Ô´´ Restraints
3 Competition Landscape by Key Players
3.1 Global Top Melatonin Players by Revenue
3.1.1 Global Top Melatonin Players by Revenue (2018-2023)
3.1.2 Global Melatonin Revenue Âé¶¹Ô´´ Share by Players (2018-2023)
3.2 Global Melatonin Âé¶¹Ô´´ Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Melatonin Revenue
3.4 Global Melatonin Âé¶¹Ô´´ Concentration Ratio
3.4.1 Global Melatonin Âé¶¹Ô´´ Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Melatonin Revenue in 2022
3.5 Melatonin Key Players Head office and Area Served
3.6 Key Players Melatonin Product Solution and Service
3.7 Date of Enter into Melatonin Âé¶¹Ô´´
3.8 Mergers & Acquisitions, Expansion Plans
4 Melatonin Breakdown Data by Type
4.1 Global Melatonin Historic Âé¶¹Ô´´ Size by Type (2018-2023)
4.2 Global Melatonin Forecasted Âé¶¹Ô´´ Size by Type (2024-2029)
5 Melatonin Breakdown Data by Application
5.1 Global Melatonin Historic Âé¶¹Ô´´ Size by Application (2018-2023)
5.2 Global Melatonin Forecasted Âé¶¹Ô´´ Size by Application (2024-2029)
6 North America
6.1 North America Melatonin Âé¶¹Ô´´ Size (2018-2029)
6.2 North America Melatonin Âé¶¹Ô´´ Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Melatonin Âé¶¹Ô´´ Size by Country (2018-2023)
6.4 North America Melatonin Âé¶¹Ô´´ Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Melatonin Âé¶¹Ô´´ Size (2018-2029)
7.2 Europe Melatonin Âé¶¹Ô´´ Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Melatonin Âé¶¹Ô´´ Size by Country (2018-2023)
7.4 Europe Melatonin Âé¶¹Ô´´ Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Melatonin Âé¶¹Ô´´ Size (2018-2029)
8.2 Asia-Pacific Melatonin Âé¶¹Ô´´ Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Melatonin Âé¶¹Ô´´ Size by Region (2018-2023)
8.4 Asia-Pacific Melatonin Âé¶¹Ô´´ Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Melatonin Âé¶¹Ô´´ Size (2018-2029)
9.2 Latin America Melatonin Âé¶¹Ô´´ Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Melatonin Âé¶¹Ô´´ Size by Country (2018-2023)
9.4 Latin America Melatonin Âé¶¹Ô´´ Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Melatonin Âé¶¹Ô´´ Size (2018-2029)
10.2 Middle East & Africa Melatonin Âé¶¹Ô´´ Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Melatonin Âé¶¹Ô´´ Size by Country (2018-2023)
10.4 Middle East & Africa Melatonin Âé¶¹Ô´´ Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Natrol
11.1.1 Natrol Company Detail
11.1.2 Natrol Business Overview
11.1.3 Natrol Melatonin Introduction
11.1.4 Natrol Revenue in Melatonin Business (2018-2023)
11.1.5 Natrol Recent Development
11.2 Pharmavite
11.2.1 Pharmavite Company Detail
11.2.2 Pharmavite Business Overview
11.2.3 Pharmavite Melatonin Introduction
11.2.4 Pharmavite Revenue in Melatonin Business (2018-2023)
11.2.5 Pharmavite Recent Development
11.3 Nature's Bounty
11.3.1 Nature's Bounty Company Detail
11.3.2 Nature's Bounty Business Overview
11.3.3 Nature's Bounty Melatonin Introduction
11.3.4 Nature's Bounty Revenue in Melatonin Business (2018-2023)
11.3.5 Nature's Bounty Recent Development
11.4 Jameison
11.4.1 Jameison Company Detail
11.4.2 Jameison Business Overview
11.4.3 Jameison Melatonin Introduction
11.4.4 Jameison Revenue in Melatonin Business (2018-2023)
11.4.5 Jameison Recent Development
11.5 Rexall Sundown
11.5.1 Rexall Sundown Company Detail
11.5.2 Rexall Sundown Business Overview
11.5.3 Rexall Sundown Melatonin Introduction
11.5.4 Rexall Sundown Revenue in Melatonin Business (2018-2023)
11.5.5 Rexall Sundown Recent Development
11.6 GNC
11.6.1 GNC Company Detail
11.6.2 GNC Business Overview
11.6.3 GNC Melatonin Introduction
11.6.4 GNC Revenue in Melatonin Business (2018-2023)
11.6.5 GNC Recent Development
11.7 Xiu Zheng
11.7.1 Xiu Zheng Company Detail
11.7.2 Xiu Zheng Business Overview
11.7.3 Xiu Zheng Melatonin Introduction
11.7.4 Xiu Zheng Revenue in Melatonin Business (2018-2023)
11.7.5 Xiu Zheng Recent Development
11.8 Church & Dwight
11.8.1 Church & Dwight Company Detail
11.8.2 Church & Dwight Business Overview
11.8.3 Church & Dwight Melatonin Introduction
11.8.4 Church & Dwight Revenue in Melatonin Business (2018-2023)
11.8.5 Church & Dwight Recent Development
11.9 By-Health
11.9.1 By-Health Company Detail
11.9.2 By-Health Business Overview
11.9.3 By-Health Melatonin Introduction
11.9.4 By-Health Revenue in Melatonin Business (2018-2023)
11.9.5 By-Health Recent Development
11.10 Pfizer
11.10.1 Pfizer Company Detail
11.10.2 Pfizer Business Overview
11.10.3 Pfizer Melatonin Introduction
11.10.4 Pfizer Revenue in Melatonin Business (2018-2023)
11.10.5 Pfizer Recent Development
11.11 Solgar
11.11.1 Solgar Company Detail
11.11.2 Solgar Business Overview
11.11.3 Solgar Melatonin Introduction
11.11.4 Solgar Revenue in Melatonin Business (2018-2023)
11.11.5 Solgar Recent Development
11.12 Biotics Research
11.12.1 Biotics Research Company Detail
11.12.2 Biotics Research Business Overview
11.12.3 Biotics Research Melatonin Introduction
11.12.4 Biotics Research Revenue in Melatonin Business (2018-2023)
11.12.5 Biotics Research Recent Development
11.13 Now Food
11.13.1 Now Food Company Detail
11.13.2 Now Food Business Overview
11.13.3 Now Food Melatonin Introduction
11.13.4 Now Food Revenue in Melatonin Business (2018-2023)
11.13.5 Now Food Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Natrol
Pharmavite
Nature's Bounty
Jameison
Rexall Sundown
GNC
Xiu Zheng
Church & Dwight
By-Health
Pfizer
Solgar
Biotics Research
Now Food
Ìý
Ìý
*If Applicable.